Search company, investor...

Tenaxis Medical

tenaxismedical.com

Founded Year

2004

Stage

Debt - V | Alive

Total Raised

$33.25M

Last Raised

$1.38M | 9 yrs ago

About Tenaxis Medical

Tenaxis Medical develops and commercializes high-performance sealants and anti-adhesion agents for use in vascular and general surgery. The company's primary focus is to create products that meet unfulfilled needs in these fields. Its first product, ArterX Surgical Sealant, is based upon a crosslinking agent that covalently binds to proteins in both the sealant and human tissue.

Headquarters Location

835 Maude Avenue

Mountain View, California, 94043,

United States

650-691-9016

Missing: Tenaxis Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Tenaxis Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Tenaxis Medical Patents

Tenaxis Medical has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/16/2013

5/7/2019

Dicarboxylic acids, Biomaterials, Aldehydes, Polymers, Monomers

Grant

Application Date

10/16/2013

Grant Date

5/7/2019

Title

Related Topics

Dicarboxylic acids, Biomaterials, Aldehydes, Polymers, Monomers

Status

Grant

Latest Tenaxis Medical News

Tenaxis Medical hauls in $1M

Feb 7, 2014

February 7, 2014 by Chris Walker Tenaxis Medical hauls in more than $1 million in a still-open funding round. Tenaxis Medical said it brought in close to $1.4 million in a still-open funding round. The Mountain View, Calif.-based medical device company develops and commercializes surgical sealants for vascular and general procedures. Sign up to get our free newsletters delivered straight to your inbox Tenaxis' marquee product, the ArterX sealant for vascular procedures, uses a prophylactic agent that binds to proteins in both the sealant and the tissue to cross-link them. The sealant has won approval in the U.S. and Europe, according to the Tenaxis website . The debts-and-warrants round already involves some 30 unnamed investors, according to a regulatory filing . Tenaxis is hoping to raise total of $1.5 million, according to the filing.

Tenaxis Medical Frequently Asked Questions (FAQ)

  • When was Tenaxis Medical founded?

    Tenaxis Medical was founded in 2004.

  • Where is Tenaxis Medical's headquarters?

    Tenaxis Medical's headquarters is located at 835 Maude Avenue, Mountain View.

  • What is Tenaxis Medical's latest funding round?

    Tenaxis Medical's latest funding round is Debt - V.

  • How much did Tenaxis Medical raise?

    Tenaxis Medical raised a total of $33.25M.

  • Who are the investors of Tenaxis Medical?

    Investors of Tenaxis Medical include Magic Venture Capital and Matrix Medical Network.

  • Who are Tenaxis Medical's competitors?

    Competitors of Tenaxis Medical include IlluminOss Medical, MAKO Surgical, Vibrynt, Aragon Surgical, Symbios Medical Products and 12 more.

Compare Tenaxis Medical to Competitors

V
Vibrynt

Vibrynt is a medical device company developing an implant for the treatment of morbid obesity.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

F
Focal

Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.

C
Clearmedical

ClearMedical is a distributor of remanufactured brand name surgical devices. ClearMedical aims to drive cost savings by selling high-volume, disposable, FDA approved laparoscopic, arthroscopic, and general surgical devices at reduced prices. The company collects used Single-Use-Devices (SUDs) from hospitals, reprocesses them consistent with FDA approvals, and sells them to hospitals and surgery centers wanting to reduce supply acquisition costs. The company's device list includes harmonic scalpels from Ethicon, trocars from Ethicon, US Surgical (AutoSuture), laparoscopic instruments from Ethicon, US Surgical (AutoSuture), clip appliers from ethicon, US Surgical (AutoSuture), linear cutter and staplers from Ethicon, and bone shavers from Linvatec, Smith & Nephew, and Stryker.

E
Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

i
iBalance

iBalance, Inc. is developing an improved method for completing an orthopedic surgical procedure called high tibial osteotomy. The company aims to provide the surgical tools and implant for this knee malalignment corrective surgery.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.